Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| WOK | Work Medical Technology Group Ltd | $2.10 | $0.35 | 1667.14% | 147K | $18K | $1.85$60,000.00 |
| XAIR | Beyond Air | $2.54 | $1.67 | 190.08% | 303.6M | $7.0M | $0.67$10.40 |
| AHMA | Ambitions Enterprise Management L.l.c | $10.61 | $5.33 | 100.95% | 36.1M | $156M | $4.00$18.20 |
| THH | TryHard | $39.30 | $16.20 | 70.13% | 344.7K | $1.2B | $4.00$43.02 |
| MRNO | Murano Global Investments Plc | $2.23 | $0.76 | 51.70% | 2M | $117M | $0.49$13.25 |
| BCTX | BriaCell Therapeutics | $10.09 | $2.45 | 32.07% | 6.4M | $14M | $6.00$98.20 |
| IOTR | iOThree | $3.32 | $0.71 | 27.20% | 21M | $6.7M | $2.24$59.80 |
| ICU | SeaStar Medical | $2.80 | $0.50 | 21.73% | 279.2K | $8.7M | $2.20$30.70 |
| PMAX | Powell Max | $2.19 | $0.39 | 21.67% | 18.2M | $5.2M | $1.56$18.00 |
| TTMI | TTM Technologies | $93.00 | $15.11 | 19.39% | 4.1M | $8.0B | $15.77$95.46 |
Related Articles
Featured Article
Can This Stock Double Again in 2026?
Prosper Junior Bakiny|Jan 11, 2026
It's a tough act to follow.
This Under-the-Radar Healthcare Stock Could Soar in 2026
Prosper Junior Bakiny|Sep 12, 2025
We should know a lot more by year-end.
Bargain Hunting: 2 Top Stocks to Buy Before 2025
Matt Frankel, CFP and Tyler Crowe|Sep 7, 2024
There are some cheap stocks in the market, and here are two in particular that could be worth a closer look.
Advertisement
Could Structure Therapeutics Become the Next Novo Nordisk?
Alex Carchidi|Jun 17, 2024
Becoming the next Novo Nordisk is a long shot, but it's more likely than it sounds.
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
Cory Renauer|Jun 11, 2024
Analysts who follow the start-up drugmaker think its stock has a chance to soar, but that doesn't mean it's right for you.
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Alex Carchidi|Jun 9, 2024
Structure Therapeutics has a long way to go before beating Wegovy.
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
Alex Carchidi|Dec 25, 2023
It has genuine struggles ahead, but it has some actual value in hand as well.
As Wall Street Rallies, Investors Are Losing Patience With These 2 Stocks
Dan Caplinger|Nov 8, 2023
Despite past successes, these two companies aren't living up to high expectations.
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
James Brumley|Nov 3, 2023
Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.
This $1.1 Trillion Industry Could Be Worth $3.8 Trillion by 2030: 3 Stocks Set to Skyrocket
Matt DiLallo, Tyler Crowe, and Jason Hall|Oct 22, 2023
These companies are in prime positions to capitalize on the massive and growing renewable energy market.
